Abstract
Metabolic syndrome (MS) is a disease with an inflammatory component. Telmisartan improves insulin resistance in MS, but its relationship with the inflammatory state is unknown. We investigated the effect of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have